Sera from patients suffering from Crohn's and other diseases and from healthy subjects were tested for agglutinins to anaerobic, gram-positive coccoid rods belonging to species of Eubacterium and Peptostreptococcus. Four strains labelled Eubacterium contortum (two strains), Eubacterium rectale and Peptostreptococcus productus were agglutinated by a higher percentage of sera from patients with Crohn's disease than from healthy subjects and from patients with liver and intestinal diseases (including ulcerative colitis), ankylosing spondylitis, granulomatous diseases, diseases of immunity and malignancies.
INTRODUCTION
The faecal flora of patients with Crohn's disease of the terminal ileum contains a higher number of anaerobic gram-negative and gram-positive coccoid rods than the flora of healthy subjects. Neither duration of illness nor ileocaecal resection had an effect on flora composition (Wensinck et al. 1981) .
In a preliminary study it was found that sera from patients with Crohn's disease agglutinate a strain of Eubacterium contortum more frequently than sera from patients with other diseases and sera from healthy subjects (Wensinck, 1975 (Wensinck, , 1976 . Twenty-five isolates belonging to species of Eubacterium and Peptostreptococcus have been tested and, except for a few strains that were not agglutinated, most were agglutinated by a higher percentage of sera from patients with Crohn's disease than from healthy subjects. Four strains were selected for their capacity to discriminate between sera from patients with Crohn's disease and sera from 14
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healthy subjects. The agglutination of these strains by sera from healthy subjects and from patients with Crohn's and other diseases is reported here. The results have been used to estimate the probability that a patient suffers from Crohn's disease by means of an interpretation based on discriminant analysis (Van de Merwe, Schmitz & Wensinck, 1981). Subsequently, sera submitted for the establishment of the diagnosis of Crohn's disease have also been interpreted in this way.
MATERIALS AND METHODS

Patients
Sera were provided by physicians from various hospitals (see acknowledgements). Requests for serum included specifications of certain clinical features and laboratory findings. The patients suffering from Crohn's disease and other diseases (called 'control' diseases) were considered by their physicians to represent the classical diseases. Patients with Crohn's disease were under treatment at the Departments of Internal Medicine II and Surgery, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands. The healthy subjects were blood donors (Red Cross Transfusion Service, Rotterdam). The 'control' diseases are listed in Table 1 and include diseases of the intestinal tract and liver, ankylosing spondylitis, diseases of immunity (atopy, rheumatoid arthritis), granulomatous diseases (leprosy, tuberculosis, sarcoidosis) and malignant disease. Some relevant clinical data are given in the table.
The diagnosis was uncertain in many patients from whom serum was submitted for the establishment of the diagnosis of Crohn's disease. Detailed clinical information was requested in all cases with positive serological results.
Bacteria
Three strains of gram-positive coccoid anaerobes (code numbers ME 44 , ME 46 and ME 47 ) were isolated from the faeces of patients with Crohn's disease as described by Wensinck et al. (1981) . One strain (C 18 ), labelled Peptostreptococcus products, was received from Dr W. E. C. Moore (Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA). Some characteristics of the strains are given in Table 2 . Two strains (ME 44 and ME 47 ) were identified as Eubacterium amlortum, one (ME 4e ) as Eubacterium rectale and one (C lg ) as P. productus.
Bacterial suspensions
Suspensions were prepared from cultures in anaerobic broth (Wensinck et al. 1981) grown for 24-48 h at 37 °C. Formaldehyde solution was added to a final concentration of 0*5% and, after incubation for 18 h at 37 °C, the bacteria were washed twice and resuspended in 0*85% (w/v) saline with 0-01 % (w/v) sodium ethylmercurithiosalicylate. Cell density was adjusted to 5 x 10* bacteria per ml and pH to 6*8-7*0; the pH of freshly prepared suspensions had to be re-adjusted after 3-4 days and the suspensions were checked monthly for contamination. 
Agglutination test
Sera were tested within three days after collection. Two drops of serum and one drop of bacterial suspension were thoroughly mixed with a platinum loop on a slide that was shaken (150 rev./min) on the platform of a rotary mixer (Mini-Shaker, Kuhner A.G., Basel, Switzerland). Results were scored after 5 min as negative (0) or positive (1,2 or 3 according to strength of agglutination). With strongly positive sera (score 3), the agglutinate consisted of a clump and the surrounding fluid was clear. Inactivation of complement (30 min at 56 °C) or storage at -40 °C had no effect on agglutination titres.
Titres were determined with doubling dilutions of serum in 0*85% saline. For agglutinin absorption, the bacterial sediment of 1 ml of suspension was resuspended in 1 ml of serum; after 1 h at room temperature, the supernatant was withdrawn after centrifugation.
Antisera
Antisera were prepared in New Zealand White female rabbits by intramuscular injection of 1 ml of bacterial suspension twice weekly for 3 weeks.
Immunoglobulin class of agglutinins
The sera from patients with Crohn's disease were applied to a Sephadex G 
Gas +
Final pH 4-7 Fermentation products E, A, F + = acid produced; -= no acid produced; A E = ethanol; F = formic acid; L = lactic acid. ME, 7 ME,, 
Statistical methods
Results from different groups were compared using the x 2 test with Yates' correction for continuity. The strength of agglutination should be considered when the tests with four strains were used to obtain one combined result. This was achieved by using discriminant analysis to estimate the probability that a patient suffers from Crohn's disease (Van de Merwe, Schmitz & Wensinck, 1981). In the present report, sera with agglutination reactions giving an a posteriori probabilitŷ 0-95 were considered positive.
RESULTS
Results are presented under three headings:
(1) patients with Crohn's disease and healthy subjects; data on titres, absorption and immunoglobulin class of agglutinins are also given in this section; (2) 'control' disease and (3) sera submitted for diagnosis. Patients with Crohn's disease and healthy subjects The data in Tables 3-6 show that the four strains were agglutinated more frequently by sera from patients with Crohn's disease than by sera from healthy subjects. Fifty-four per cent of the patients with Crohn's disease were positive (a posteriori probability > 0*95) whereas all healthy subjects were negative (Table 7) .
The agglutination titres of strongly positive Crohn's sera (score 3) were low (1/16-1/32).
Rabbit immune sera agglutinated the strains to titres of 1/32-1/64 and showed no cross-reactivity. Accordingly, the agglutinins were absorbed specifically from Crohn's sera as shown in Table 8 .
In most sera, the agglutinins were present in the IgG or IgG + IgM fractions (Table 9) .
'Control' diseases Table 3 shows that strain ME 44 (Eubacterium contortum) was agglutinated by sera from 'control' patients with percentages not significantly different from the value in healthy subjects.
The other strain of E. contortum (ME 47 ) was agglutinated more frequently by sera from patients with large bowel carcinoma but percentages of other 'control' diseases were not significantly different from that in healthy subjects (Table 4) .
Strain ME 4C (E. rectale) was also agglutinated more frequently by patients with colonic carcinoma. It also showed a higher than normal percentage in ulcerative colitis patients; the percentage was however much lower than in patients with Crohn'8 disease (Table 5) .
Sera from patients with various 'control' diseases agglutinated P. producing (strain C 18 ) more frequently than did sera from healthy subjects (Table 6 ) but the percentages were significantly lower than in Crohn's disease.
The percentages of positive sera as calculated from the combined results with four strains are shown in Table 7 . They were higher than normal in cirrhosis of liver, coeliac disease and ulcerative colitis but significantly lower than in Crohn's disease.
Sera submitted for diagnosis Of a sample representing about one-quarter of the sera received for diagnostic purposes in 1978, 21 % was positive (Table 10 ). In about 60% of the positive cases the diagnosis of Crohn's disease had been established. In 27% of the patients, symptoms suggested Crohn's colitis or ulcerative colitis and 8 % showed presenting symptoms of Crohn's disease.
Serological results in these patients cannot be interpreted satisfactorily until the course of the disease allows a firm diagnosis. In 3 % of the positive cases, the clinical histories appeared incompatible with the diagnosis of Crohn's disease. This Agglutination of coccoid anaerobes in Crohn's disease 19 percentage appears acceptable, because sera were considered positive when the probability of Crohn's disease was ^ 0*95, implying that 5 % of positive results may occur in patients without Crohn's disease.
DISCUSSION
The finding that intestinal coccoid anaerobes are agglutinated more frequently by sera from patients with Crohn's disease than from healthy subjects is compatible with data showing that these patients produce antibodies to a wide range of food and microbial antigens like bovine serum albumin (Falchuk & Isselbacher, 1976 In the present study, sera from 54 % of the patients with Crohn's disease were positive with an a posteriori probability of ^ 0*95. In a study of correlations between agglutination reactions and clinical data of Crohn's and ulcerative colitis patients we found that agglutination was positively correlated with localization of Crohn's disease in the colon, with the presence of fistulae and with levels of serum immunoglobulins (Van de Merwe, 1980) . There is one striking difference between the studies on antibody production mentioned and our results. Antibodies to the various food and microbial antigens were present in both Crohn's and ulcerative colitis patients but, with the coccoid anaerobes, results in these diseases were significantly different. From the group of 48 ulcerative colitis patients, 12% were positive (P ^ 0-95) and from the Crohn's patients 54 %. Moreover, the percentages of sera that were negative with all strains were 79% in healthy subjects, 65% in ulcerative colitis and 17% in Crohn's patients; the differences between Crohn's patients and the two other groups were highly significant. In view of the well-known difficulties with the differential diagnosis of these conditions, reviewed by Kirsner (1975) , we feel that misdiagnosis should be considered when serological reactions are positive in patients presumed to suffer from ulcerative colitis.
From the 'control' diseases, coeliac disease and cirrhosis of liver showed slightly higher percentages of positive sera than normal. Cirrhosis, schistosomiasis, ankylosing spondylitis, atopy and two granulomatous diseases (leprosy, tuberculosis) had relatively high percentages of C 18 positive sera. Because agglutination of strain Crohn's disease Healthy subjects * Positive: a posteriori probability ^ 0-95 with a priori probability = 0*5. P-value of difference with healthy subjects in parentheses; values not given when P > 0-05. -indicates not tested with four strains. Table 8 . Agglutination of strains ME U , ME i7 , ME M and C 18 by two Crohn's sera before and after absorption * Strain ME 44 , ME 47 , ME 4 , and C u respectively, according to strength of agglutination.
C 18 was correlated with IgG levels in Crohn's patients, the frequent agglutination of C 18 in 'control' diseases may also be due to hyperglobulinaemia which occurs in a rather high number of patients suffering from liver diseases (Triger & Wright, 1973) , schistosomiasis (Camus et at. 1977) and leprosy (Bullock, 1971) . Ideally, the interpretation of a diagnostic test should be based on the results from samples of the patient population and a similar population differing only by 
